Protein E7(43-62) (TFA)
Katalog-Nummer HY-P2299A
Size : Getquote
Marke : MedChemExpress
Protein E7(43-62) TFA is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
Kundenspezifische Peptidsynthese
Protein E7(43-62) TFA Chemische Struktur
This product is a controlled substance and not for sale in your territory.
Beschreibung |
Protein E7(43-62) TFA is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein)[1]. |
---|---|
In Vivo |
Using an E7-derived peptide Protein E7(43-62), 50% of mice (C57BL/6 mice bearing human papilloma virus (HPV) E6/7 TC-1 tumors) are tumor free 60 days after treatment with Protein E7(43-62)-polymeric nanoparticle (PC7A NP)[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
Molekulargewicht |
2384.54 |
Formel |
C97H145N28F3O33S3 |
Sequence Shortening |
GQAEPDRAHYNIVTFCCKCD |
Versand | Room temperature in continental US; may vary elsewhere. |
Speicherung |
Please store the product under the recommended conditions in the Certificate of Analysis. |
Reinheit & Dokumentation | |
Verweise |
|
Protein E7(43-62) TFA Related Classifications
- Cancer
- Cancer Metabolism and Metastasis
Molaritätsrechner
Verdünnungsrechner
Die Formel zur Berechnung von Molaritäten
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2
-
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.
Keywords:
Protein E7(43-62)OthersPC7Ananoparticleanti-tumorpeptidimmunotherapySTINGnanovaccineInhibitorinhibitorinhibit